Sat, Dec 27, 2014, 3:21 AM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Cytori Therapeutics, Inc. Message Board

  • desertdawglives desertdawglives Mar 3, 2014 1:17 PM Flag

    Update Report on Japan

    3 horse race according to SA

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • BJ's from Athersys talk about Japan:
      "The new Regenerative Medicine Law and revised Pharmaceutical Affairs Law defines products containing stem cells as regenerative medicine products, allowing for the conditional approval of such a product if safety has been confirmed in clinical trials, even if efficacy has not been fully demonstrated. The legislation creates new faster pathways for cell therapy product approval, creating the potential for more rapid entry in the Japanese market.
      CYTX and ATHX will benefit from this new legislation. BARDA and Japan are the most important drivers at this moment, imo.

      Sentiment: Strong Buy

    • Cytori Therapeutics (CYTX) has been investing in Japan for more than 10 years and has a well-established presence with its Tokyo-based medical subsidiary Cytori Therapeutics K.K. Cytori is engaged in development of therapies centered on autologous adipose (fat)-derived regenerative cells for treating cardiovascular disease and other conditions. The company has already conducted several clinical trials in Japan with more underway that have shown a consistent safety profile for Cytori's technologies. Cytori also offers StemSource(R), a cell bank product line, that could see an uptick in use as stem cell research increases in Japan.

      Regenerative medicine on the whole appears to have gotten some wind behind its sails, thanks to advances on multiple fronts, including the progress being achieved by leading companies, and the regulatory progress in Japan, as well as in other countries. Spearheaded by so-called Abenomics, the country has charted a course for change that includes planting its ensign as a pioneer in regenerative medicine and the clinical process, one that can inspire investment for the benefit of its country and the world over.

    • My apologies, not SA but from accesswire

 
CYTX
0.50+0.02(+4.19%)Dec 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
PG&E Corporation
NYSEFri, Dec 26, 2014 4:02 PM EST